• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)与北美儿科胃肠病、肝病和营养学会(NASPGHAN)2024年儿童功能性便秘治疗指南方案(标准操作程序)

ESPGHAN and NASPGHAN 2024 protocol for paediatric functional constipation treatment guidelines (standard operating procedure).

作者信息

Gordon Morris, de Geus Anna, Banasiuk Marcin, Benninga Marc A, Borrelli Osvaldo, Boruta Mary, Darbari Anil, Dore-Stites Dawn, Gould Michelle, Hawa Juliette, Jones Kirsten Brooke, Khlevner Julie, Kilgore Alexandra, Mousa Hayat, Nurko Samuel, Sinopoulou Vassiliki, Tabbers Merit, Thapar Nikhil

机构信息

University of Central Lancashire, Preston, UK

Peadiatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

出版信息

BMJ Paediatr Open. 2025 Feb 4;9(1):e003161. doi: 10.1136/bmjpo-2024-003161.

DOI:10.1136/bmjpo-2024-003161
PMID:39904543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11795385/
Abstract

INTRODUCTION

Functional constipation is common in childhood, with chronicity leading to a significant impact on patients and their families. There is a significant range of therapies available to healthcare professionals for this condition, with many novel or recently studied. There is a need for an update to the joint European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) guidelines last released in 2014. We present the prospectively agreed operating procedure and technical review protocol in this manuscript.

METHODS

'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) will be used for all phases of this guideline development. The Guideline Development Group is formed by paediatric gastroenterologists from both the ESPGHAN as well as the NASPGHAN. A prospective exercise will agree on key outcomes, thresholds of magnitude that are significant at small, moderate and large levels. Systematic evidence searches, selection, extraction, appraisal and analysis will be performed following Cochrane guidance and GRADE guidance for objectively agreeing the certainty of findings. Additional use of network meta-analysis will identify areas of broad triangulation in the evidence. Summary of findings tables will be produced and inform evidence to decision frameworks. These will guide GRADE recommendations with voting to reach a consensus.

摘要

引言

功能性便秘在儿童中很常见,其慢性特征会对患者及其家庭产生重大影响。医疗保健专业人员针对这种情况有多种治疗方法可供选择,其中许多是新颖的或最近研究过的。2014年发布的欧洲儿科胃肠病学、肝病学和营养学会(ESPGHAN)/北美儿科胃肠病学、肝病学和营养学会(NASPGHAN)联合指南需要更新。我们在本手稿中介绍了前瞻性商定的操作程序和技术审查方案。

方法

本指南制定的所有阶段都将使用“推荐分级评估、制定和评价”(GRADE)方法。指南制定小组由ESPGHAN和NASPGHAN的儿科胃肠病学家组成。一项前瞻性工作将确定关键结果、在小、中、大水平上具有显著意义的量级阈值。将按照Cochrane指南和GRADE指南进行系统的证据检索、选择、提取、评估和分析,以客观确定研究结果的确定性。额外使用网络荟萃分析将确定证据中广泛三角测量的领域。将编制研究结果总结表,并为决策框架提供证据。这些将指导GRADE推荐并通过投票达成共识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7a/11795385/98f19bb4510d/bmjpo-9-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7a/11795385/16406ae5c875/bmjpo-9-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7a/11795385/98f19bb4510d/bmjpo-9-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7a/11795385/16406ae5c875/bmjpo-9-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7a/11795385/98f19bb4510d/bmjpo-9-1-g002.jpg

相似文献

1
ESPGHAN and NASPGHAN 2024 protocol for paediatric functional constipation treatment guidelines (standard operating procedure).欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)与北美儿科胃肠病、肝病和营养学会(NASPGHAN)2024年儿童功能性便秘治疗指南方案(标准操作程序)
BMJ Paediatr Open. 2025 Feb 4;9(1):e003161. doi: 10.1136/bmjpo-2024-003161.
2
ESPGHAN and NASPGHAN 2023 protocol for paediatric FAPD treatment guidelines (standard operating procedure).ESPGHAN 和 NASPGHAN 2023 年儿童 FAPD 治疗指南(标准操作程序)。
BMJ Paediatr Open. 2023 Dec 20;7(1):e002166. doi: 10.1136/bmjpo-2023-002166.
3
Evaluation and treatment of constipation in children: summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.儿童便秘的评估与治疗:北美儿科胃肠病学、肝病学和营养学会最新建议总结
J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):405-7. doi: 10.1097/01.mpg.0000232574.41149.0a.
4
Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN.婴幼儿功能性便秘的评估与治疗:欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)及北美儿科胃肠病、肝病和营养学会(NASPGHAN)的循证推荐意见
J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):258-74. doi: 10.1097/MPG.0000000000000266.
5
Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN).小儿胃食管反流临床实践指南:北美小儿胃肠病学、肝病学和营养学学会(NASPGHAN)和欧洲小儿胃肠病学、肝病学和营养学学会(ESPGHAN)的联合建议。
J Pediatr Gastroenterol Nutr. 2009 Oct;49(4):498-547. doi: 10.1097/MPG.0b013e3181b7f563.
6
Awareness and Implementation of the 2014 ESPGHAN/NASPGHAN Guideline for Childhood Functional Constipation.2014年ESPGHAN/NASPGHAN儿童功能性便秘指南的认知与实施
J Pediatr Gastroenterol Nutr. 2018 May;66(5):732-737. doi: 10.1097/MPG.0000000000001786.
7
Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis.儿童嗜酸性粒细胞性胃肠道疾病除嗜酸性食管炎以外的 ESPGHAN/NASPGHAN 指南
J Pediatr Gastroenterol Nutr. 2024 Jan;78(1):122-152. doi: 10.1097/MPG.0000000000003877. Epub 2023 Jul 4.
8
Chapter 2. ESPGHAN: 50 Years Memories-The Early Years.第2章. 欧洲儿科胃肠病、肝病和营养学会(ESPGHAN):50年的回忆——早期岁月。
J Pediatr Gastroenterol Nutr. 2018 Apr;66 Suppl 1:S20-S28. doi: 10.1097/MPG.0000000000001912.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Chapter 8. 50 Years of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Captivating Witness Reports of a Success Story.第8章. 欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)的50年:成功故事的引人入胜的见证报告
J Pediatr Gastroenterol Nutr. 2018 Apr;66 Suppl 1:S154-S171. doi: 10.1097/MPG.0000000000001919.

引用本文的文献

1
Constipation in Children with Cerebral Palsy: Prevalence, Clinical Manifestations, and Polyethylene glycol vs. Lactulose Efficacy.脑瘫患儿的便秘:患病率、临床表现以及聚乙二醇与乳果糖的疗效比较
Iran J Child Neurol. 2025 Jun 23;19(3):71-76. doi: 10.22037/ijcn.v19i3.45043. eCollection 2025 Summer.
2
Epidemiology of childhood constipation: a national study of Swedish children from 2006 to 2023.儿童便秘的流行病学:一项对2006年至2023年瑞典儿童的全国性研究。
BMC Pediatr. 2025 Jul 3;25(1):525. doi: 10.1186/s12887-025-05858-4.
3
Do Most Children with Functional Constipation Meet the Commonly Used Clinical Trial Endpoints?

本文引用的文献

1
How do we define therapy-resistant constipation in children aged 4-18 years old? A systematic review with meta-narrative synthesis.如何定义 4-18 岁儿童的治疗抵抗性便秘?系统评价与元叙述综合。
BMJ Paediatr Open. 2024 Jun 6;8(1):e002380. doi: 10.1136/bmjpo-2023-002380.
2
Maintaining remission in Crohn's disease post surgery: what can we learn from Cochrane?克罗恩病术后维持缓解:我们能从Cochrane协作网中学到什么?
Frontline Gastroenterol. 2024 Jan 17;15(3):241-246. doi: 10.1136/flgastro-2023-102559. eCollection 2024 May.
3
ESPGHAN and NASPGHAN 2023 protocol for paediatric FAPD treatment guidelines (standard operating procedure).
大多数功能性便秘儿童是否符合常用的临床试验终点?
Children (Basel). 2025 Feb 15;12(2):234. doi: 10.3390/children12020234.
ESPGHAN 和 NASPGHAN 2023 年儿童 FAPD 治疗指南(标准操作程序)。
BMJ Paediatr Open. 2023 Dec 20;7(1):e002166. doi: 10.1136/bmjpo-2023-002166.
4
BSG 2024 IBD guidelines protocol (standard operating procedures).BSG 2024 IBD 指南制定议定书(标准操作程序)。
BMJ Open Gastroenterol. 2023 Feb;10(1). doi: 10.1136/bmjgast-2022-001067.
5
Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance.好的或最佳实践声明:对 GRADE 指南的操作化和实施的建议。
BMJ Evid Based Med. 2023 Jun;28(3):189-196. doi: 10.1136/bmjebm-2022-111962. Epub 2022 Apr 15.
6
Minimum sample size estimates for trials in inflammatory bowel disease: A systematic review of a support resource.炎症性肠病试验的最小样本量估计:支持资源的系统评价。
World J Gastroenterol. 2021 Nov 21;27(43):7572-7581. doi: 10.3748/wjg.v27.i43.7572.
7
Sample-size estimation is not reported in 24% of randomised controlled trials of inflammatory bowel disease: A systematic review.24%的炎症性肠病随机对照试验未报告样本量估计:系统评价。
United European Gastroenterol J. 2021 Feb;9(1):47-53. doi: 10.1177/2050640620967899. Epub 2021 Feb 18.
8
A Core Outcome Set for Clinical Trials in Pediatric Functional Abdominal Pain Disorders.儿科功能性腹痛障碍临床试验的核心结局集。
J Pediatr. 2020 Jun;221:115-122.e5. doi: 10.1016/j.jpeds.2020.02.032. Epub 2020 Apr 17.
9
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.《可信系统评价的更新指南:干预措施系统评价的新版Cochrane手册》
Cochrane Database Syst Rev. 2019 Oct 3;10(10):ED000142. doi: 10.1002/14651858.ED000142.
10
The cost of constipation.便秘的代价。
Lancet Gastroenterol Hepatol. 2019 Nov;4(11):811. doi: 10.1016/S2468-1253(19)30297-3.